Results 211 to 220 of about 176,746 (294)

Hydroxychloroquine as an adjunct therapy in the management of type 2 diabetes in pregnancy: study protocol for a randomised controlled trial. [PDF]

BMJ Open
Basri NI, A Wahab N, Mohammed Nawi A, Ishak S, Murthi P, Abd Rahman R.   +5 more
europepmc   +1 more source

Setting up mother–infant pair lactation studies with biobanking for research according to regulatory requirements

British Journal of Clinical Pharmacology, EarlyView.
Within the ConcePTION project we set out to design two mother–infant pair studies collecting breast milk and plasma from the mother and plasma from the infant (for metformin and prednisolone) in order to demonstrate the premises and conditions for investigating potential drug transfer in association with breastfeeding.
Mats Hansson, Ida Björkgren, Jenny Svedenkrans, Helena Backman, Jarl Hellman, Linda Englund‐Ögge, Mikaela Magnusson, Inger Lindström, Andrea Wutte, Erica Sundell, Pawel Baranczewski, Laura Shaughnessy   +11 more
wiley   +1 more source

Retraction: Beyond the Curriculum: Exploring Perception of Equity, Diversity, and Inclusion Among Medical Students. [PDF]

Cureus
Alsaleh RA, Abd El-Fadeal NM, Alamoudi NM, El Tarhouny S.   +3 more
europepmc   +1 more source

How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic.

Human Reproduction, 2012
J. Naftalin, W. Hoo, K. Pateman, D. Mavrelos, T. Holland, D. Jurkovic   +5 more
semanticscholar   +1 more source

Pharmacokinetic profiles of sertraline in pregnancy as a predictor of postpartum depressive symptoms

British Journal of Clinical Pharmacology, EarlyView.
Aim To characterize pharmacokinetic changes of sertraline and its metabolite during pregnancy and postpartum, and their relationship to maternal postpartum depressive symptoms. Methods This was a prospective observational, longitudinal study of pregnant women with a major depressive disorder treated with sertraline (N = 185 women, 205 pregnancies ...
Sílvia M. Illamola, Zachary N. Stowe, Marc L. Kalin, Michael D. Evans, Catherine M. Sherwin, Maged M. Costantine, D. Jeffrey Newport, James C. Ritchie, Angela K. Birnbaum   +8 more
wiley   +1 more source

Barriers to Antenatal Care Attendance in Developing Countries: A Systematic Review. [PDF]

Cureus
Abdalla Osman Mohamed S, Mohamed GS, Attaelmanan Mahgoub AK, Ahmed F, Taha AB, Abbashar Abdelmahmoud EM, Safieldin Mahamad SM, Majzoub Karamalla SB, Taha M.   +8 more
europepmc   +1 more source

Robot-assisted surgery in gynaecology.

Cochrane Database of Systematic Reviews, 2014
Hongqian Liu, T. Lawrie, D. Lu, Huan Song, Lei Wang, G. Shi   +5 more
semanticscholar   +1 more source

Human vs. artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counselling

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky, Stefan Engeli, Stefanie M. Bode‐Böger, Felix Koop, Martin Schulze Westhoff, Sebastian Schröder, Carsten Schumacher, Thorben Pape, Dirk O. Stichtenoth, Johannes Heck   +9 more
wiley   +1 more source

Correction: The Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women With Rheumatic Heart Disease and Valves Replacement. [PDF]

Cureus
Alghamdi N, Alqahtani S, Allehyani L, Alosaimi H, Almutairi W, Alobaid S, Albackr HB, Aldakhil L, Alotaibi GS, Alqahtani FH.   +9 more
europepmc   +1 more source

Low‐intervention clinical trials in Spain: Do they progress?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza, Mayro J. Cortés Pestana, Kristopher Amaro, Rosa M. Antonijoan, Caridad Pontes   +4 more
wiley   +1 more source